REZIPRES Trademark

Trademark Overview

On Sunday, July 19, 2020, a trademark application was filed for REZIPRES with the United States Patent and Trademark Office. The USPTO has given the REZIPRES trademark a serial number of 90060774. The federal status of this trademark filing is REGISTERED as of Tuesday, May 2, 2023. This trademark is owned by Eton Pharmaceuticals, Inc.. The REZIPRES trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for treatment of hypotension; pharmaceutical compositions for treatment of hypotension; pharmaceutical formulations for treatment of hypotension in the setting of anesthesia; pharmaceutical formulations containing ephedrine for treatment of clinically important hypotension in the setting of anesthesia; pharmaceutical formulations for treatment of hypotension
rezipres

General Information

Serial Number90060774
Word MarkREZIPRES
Filing DateSunday, July 19, 2020
Status700 - REGISTERED
Status DateTuesday, May 2, 2023
Registration Number7043502
Registration DateTuesday, May 2, 2023
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 17, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparations for treatment of hypotension; pharmaceutical compositions for treatment of hypotension; pharmaceutical formulations for treatment of hypotension in the setting of anesthesia; pharmaceutical formulations containing ephedrine for treatment of clinically important hypotension in the setting of anesthesia; pharmaceutical formulations for treatment of hypotension

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, August 14, 2020
Primary Code005
First Use Anywhere DateMonday, March 14, 2022
First Use In Commerce DateMonday, March 14, 2022

Trademark Owner History

Party NameDr. Reddy's Laboratories S.A.
Party Type30 - Original Registrant
Legal Entity Type11 - Company
AddressBasel 4051
CH
Party NameDr. Reddy's Laboratories S.A.
Party Type21 - New Owner After Publication
Legal Entity Type11 - Company
AddressBasel 4051
CH
Party NameEton Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDeer Park, IL 60010
Party NameEton Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDeer Park, IL 60010

Trademark Events

Event DateEvent Description
Wednesday, July 22, 2020NEW APPLICATION ENTERED
Friday, August 14, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, October 2, 2020ASSIGNED TO EXAMINER
Friday, October 2, 2020EXAMINERS AMENDMENT -WRITTEN
Friday, October 2, 2020EXAMINERS AMENDMENT E-MAILED
Friday, October 2, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, October 2, 2020EXAMINER'S AMENDMENT ENTERED
Monday, October 5, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 28, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 17, 2020PUBLISHED FOR OPPOSITION
Tuesday, November 17, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 12, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, June 24, 2021SOU TEAS EXTENSION RECEIVED
Thursday, June 24, 2021SOU EXTENSION 1 FILED
Thursday, June 24, 2021SOU EXTENSION 1 GRANTED
Saturday, June 26, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 11, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, January 11, 2022SOU EXTENSION 2 FILED
Tuesday, January 11, 2022SOU EXTENSION 2 GRANTED
Thursday, January 13, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 7, 2022ASSIGNED TO EXAMINER
Monday, July 11, 2022TEAS STATEMENT OF USE RECEIVED
Monday, July 11, 2022SOU TEAS EXTENSION RECEIVED
Monday, July 11, 2022USE AMENDMENT FILED
Monday, July 11, 2022SOU EXTENSION 3 FILED
Tuesday, July 12, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, July 12, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, July 12, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, July 12, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, July 12, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, July 13, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, September 2, 2022ITU LETTER MAILED, NO RESPONSE REQUIRED
Friday, September 2, 2022SOU EXTENSION 3 GRANTED
Friday, September 2, 2022STATEMENT OF USE PROCESSING COMPLETE
Saturday, September 3, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 7, 2022AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, September 29, 2022SU - NON-FINAL ACTION - WRITTEN
Thursday, September 29, 2022NON-FINAL ACTION E-MAILED
Thursday, September 29, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, March 15, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 15, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 15, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, March 30, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, March 31, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, May 2, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, May 2, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, June 4, 2024WITHDRAWAL OF ATTORNEY GRANTED
Tuesday, June 4, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED

Related Keywords

rezipres treatment pharmaceutical hypotension formulations setting anesthesia clinically important ephedrine containing